Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04440241
Other study ID # REGT_CT_19
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date December 1, 2022

Study information

Verified date September 2021
Source University of Santiago de Compostela
Contact Santiago Mareque
Phone 616 975 256?
Email smareque@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Does submerged healing of implants improve clinical and radiologic outcomes for the treatment of peri-implantitis? A number of recent systematic reviews have shown that the prevalence of periimplantitisin the population is high. Nevertheless, there appears to be no consensus on treatment standards for the management of peri-implant diseases. Also, the significant variation in the empirical use of the available therapeutic modalities seems to result in moderately effective treatment outcomes. Animal and human case series-studies have shown improved outcomes when using a submerged healing approach. However, there seems to be no randomized controlled clinical studies comparing submerged/non-submerged healing efficacy for the treatment of peri-implantitis. Since current modalities for the treatment of peri-implantitis seem to result inmoderately effective outcomes, there is an urgency to investigate treatment strategies that will result in improved patient's benefits in terms of health.


Description:

The present study will be double-blinded randomized controlled clinical trial. Patients requiring surgical treatment of peri-implantitis after non-surgical therapy will beassigned to either: Test group: submerged healing or Control group: non-submerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane. The primary aim of this study is to evaluate whether submerged healing of implants willsignificantly improve the changes in marginal bone levels measured on X-rays 12months post-treatment compared to a non-submerged healing approach for the treatment of peri-implantitis. Secondary aims include changes in clinical attachment levels, changes in probing pocket depth, recession, keratinized tissue, occurrence of bleeding on probing, suppuration on probing (PUS), marginal gingival recession (REC), full mouth plaque score (FMPS), full mouth bleeding score (FMBS), type of peri-implant bone defect, frequency and type of complications and implant loss.


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date December 1, 2022
Est. primary completion date December 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years. - Systemically healthy patients. - Presence of at least 1 implant diagnosed with peri-implantitis (peri-implant probing pocket depth =6 mm in at least 1 aspect of the implant with bleeding and/or suppuration on probing and radiographically documented marginal bone loss =3mm) according to Renvert et al. (2018), after non-surgical therapy of periimplantitis, and a 4mm deep intrabony component. - Absence of mobility of the implants. - Individual implant-supported crown or partial fixed implant supported restoration (removable prosthesis will be excluded). - Patient's smoking = 10 cigarettes/day. Exclusion Criteria: - Non-removable prostheses

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
regenerative treatment periimplantitis
Full thickness buccal and lingual flaps will be performed. After debridement of the defect using hand and ultrasonic instruments and implant surface decontamination using titanium brushes (TiBrush®) and saline Regenerative treatment will be performed only in the intrabony component of type 1 peri-implant defects. Guided bone regeneration using a bone substitute (Bio-oss®) and a resorbable membrane (bio-gide®) will be performed in the intrabony and dehiscenses areas of the defect. The surgeon will be blinded to the assignment of treatment until it is time to close the flaps.

Locations

Country Name City State
Spain Master Periodoncia. Facultad odontología Santiago De Compostela A Coruña

Sponsors (2)

Lead Sponsor Collaborator
University of Santiago de Compostela Osteology Foundation

Country where clinical trial is conducted

Spain, 

References & Publications (3)

Roccuzzo M, Bonino F, Bonino L, Dalmasso P. Surgical therapy of peri-implantitis lesions by means of a bovine-derived xenograft: comparative results of a prospective study on two different implant surfaces. J Clin Periodontol. 2011 Aug;38(8):738-45. doi: — View Citation

Schwarz F, Herten M, Sager M, Bieling K, Sculean A, Becker J. Comparison of naturally occurring and ligature-induced peri-implantitis bone defects in humans and dogs. Clin Oral Implants Res. 2007 Apr;18(2):161-70. Erratum in: Clin Oral Implants Res. 2007 — View Citation

Schwarz F, Sahm N, Schwarz K, Becker J. Impact of defect configuration on the clinical outcome following surgical regenerative therapy of peri-implantitis. J Clin Periodontol. 2010 May;37(5):449-55. doi: 10.1111/j.1600-051X.2010.01540.x. Epub 2010 Mar 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes marginal bone level measured on periapical X-rays, from the shoulder of the implant to the bottom of the bone defect next to the implant at the mesial and distal surfaces. Mean marginal bone levels between mesial and distal measurements will be calculated. baseline, 6 and 12 months
Secondary Changes Probing pocket depth distance from the margin gingival to the bottom of the peri-implant pouch. All clinical variables will be recorded with a Hu-friedy CP15 UNC millimeter probe in six points on each implant. baseline, 6 and 12 months
Secondary Changes Clinical attachment level Distance from the implant shoulder or prosthetic abutment to the bottom of the peri-implant pocket. baseline, 6 and 12 months
Secondary Change Reccesion distance from the margin of the peri-implant mucosa to the implant / abutment interface. baseline, 6 and 12 months
Secondary Change Keratinized mucosa distance from the gingival margin up to the mucogingival line. baseline, 6 and 12 months
Secondary Change blending on probing Registry of presence of bleeding by binary scale (1 bleed present / 0 bleed absent) baseline, 6 and 12 months
Secondary Change supuration Pus presence register by scale binary (1 present / 0 absent) baseline, 6 and 12 months
Secondary Change plaque score Registration of presence of plaque by binary scale on each surface (1 present / 0 absent), calculating the percentage of total surfaces in which plaque is detected by using a periodontal probe baseline, 6 and 12 months
Secondary configuration of the bone defect Based on the classification of Schwarz et al. (2007) baseline
See also
  Status Clinical Trial Phase
Recruiting NCT02196753 - PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I N/A
Recruiting NCT04731025 - Local Antibiotics for Breast Implants Phase 3